Global Drug for Organ Rejection Prophylaxis Production, Demand and Key Producers, 2022-2028
Organ rejection preventive drugs are used to prevent the immune system from attacking, destroying and clearing 'alien ingredients' such as bacteria, viruses, foreign bodies, foreign tissues and artificial materials
This report studies the global Drug for Organ Rejection Prophylaxis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug for Organ Rejection Prophylaxis, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug for Organ Rejection Prophylaxis that contribute to its increasing demand across many markets.
The global Drug for Organ Rejection Prophylaxis market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drug for Organ Rejection Prophylaxis total production and demand, 2017-2028, (K Units)
Global Drug for Organ Rejection Prophylaxis total production value, 2017-2028, (USD Million)
Global Drug for Organ Rejection Prophylaxis production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drug for Organ Rejection Prophylaxis domestic production, consumption, key domestic manufacturers and share
Global Drug for Organ Rejection Prophylaxis production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drug for Organ Rejection Prophylaxis market based on the following parameters – headquarters, production locations, products portfolio, Drug for Organ Rejection Prophylaxis revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug for Organ Rejection Prophylaxis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drug for Organ Rejection Prophylaxis Market, By Region:
1. How big is the global Drug for Organ Rejection Prophylaxis market?
2. What is the demand of the global Drug for Organ Rejection Prophylaxis market?
3. What is the year over year growth of the global Drug for Organ Rejection Prophylaxis market?
4. What is the production and production value of the global Drug for Organ Rejection Prophylaxis market?
5. Who are the key producers in the global Drug for Organ Rejection Prophylaxis market?
6. What are the growth factors driving the market demand?
This report studies the global Drug for Organ Rejection Prophylaxis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug for Organ Rejection Prophylaxis, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug for Organ Rejection Prophylaxis that contribute to its increasing demand across many markets.
The global Drug for Organ Rejection Prophylaxis market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drug for Organ Rejection Prophylaxis total production and demand, 2017-2028, (K Units)
Global Drug for Organ Rejection Prophylaxis total production value, 2017-2028, (USD Million)
Global Drug for Organ Rejection Prophylaxis production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drug for Organ Rejection Prophylaxis domestic production, consumption, key domestic manufacturers and share
Global Drug for Organ Rejection Prophylaxis production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug for Organ Rejection Prophylaxis production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drug for Organ Rejection Prophylaxis market based on the following parameters – headquarters, production locations, products portfolio, Drug for Organ Rejection Prophylaxis revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug for Organ Rejection Prophylaxis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drug for Organ Rejection Prophylaxis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Oral Liquid
- Injection
- Capsule
- Hospital
- Specialist Clinic
- Other
- Astellas Pharma US, Inc.
- Pfizer Inc.
- Bausch Health Companies Inc.
- Genentech, Inc.
- Veloxis Pharmaceuticals
- AbbVie
- Bristol Myers Squibb
- Novartis Pharmaceuticals Corp
- Sebela Pharmaceuticals Inc.
- Janssen Biotech, Inc.
- Astellas Pharma US, Inc.
- Adienne Pharma & Biotech
- Sanofi Genzyme Company
- Heumann Pharma GmbH
- Beijing Shuanglu Pharmaceutical Co., Ltd
- North China Pharmaceutical Co., Ltd
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- Tianjin Central Pharmaceutical Co., Ltd
- Nantong Jingjing Pharmaceutical Co., Ltd
- Shanghai Pharmaceutical Group
1. How big is the global Drug for Organ Rejection Prophylaxis market?
2. What is the demand of the global Drug for Organ Rejection Prophylaxis market?
3. What is the year over year growth of the global Drug for Organ Rejection Prophylaxis market?
4. What is the production and production value of the global Drug for Organ Rejection Prophylaxis market?
5. Who are the key producers in the global Drug for Organ Rejection Prophylaxis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drug for Organ Rejection Prophylaxis Introduction
1.2 World Drug for Organ Rejection Prophylaxis Supply & Forecast
1.2.1 World Drug for Organ Rejection Prophylaxis Production Value (2017 & 2021 & 2028)
1.2.2 World Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.2.3 World Drug for Organ Rejection Prophylaxis Pricing Trends (2017-2028)
1.3 World Drug for Organ Rejection Prophylaxis Production by Region
1.3.1 World Drug for Organ Rejection Prophylaxis Production Value by Region (2017-2028)
1.3.2 World Drug for Organ Rejection Prophylaxis Production by Region (2017-2028)
1.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Region (2017-2028)
1.3.4 North America Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.5 Europe Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.6 China Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.7 Japan Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug for Organ Rejection Prophylaxis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug for Organ Rejection Prophylaxis Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug for Organ Rejection Prophylaxis Demand (2017-2028)
2.2 World Drug for Organ Rejection Prophylaxis Consumption by Region
2.2.1 World Drug for Organ Rejection Prophylaxis Consumption by Region (2017-2022)
2.2.2 World Drug for Organ Rejection Prophylaxis Consumption Forecast by Region (2023-2028)
2.3 United States Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.4 China Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.5 Europe Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.6 Japan Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.7 South Korea Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.8 ASEAN Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.9 India Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
3 WORLD DRUG FOR ORGAN REJECTION PROPHYLAXIS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug for Organ Rejection Prophylaxis Production Value by Manufacturer (2017-2022)
3.2 World Drug for Organ Rejection Prophylaxis Production by Manufacturer (2017-2022)
3.3 World Drug for Organ Rejection Prophylaxis Average Price by Manufacturer (2017-2022)
3.4 Drug for Organ Rejection Prophylaxis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug for Organ Rejection Prophylaxis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug for Organ Rejection Prophylaxis in 2021
3.5.3 Global Concentration Ratios (CR8) for Drug for Organ Rejection Prophylaxis in 2021
3.6 Drug for Organ Rejection Prophylaxis Market: Overall Company Footprint Analysis
3.6.1 Drug for Organ Rejection Prophylaxis Market: Region Footprint
3.6.2 Drug for Organ Rejection Prophylaxis Market: Company Product Type Footprint
3.6.3 Drug for Organ Rejection Prophylaxis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Comparison
4.1.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Comparison
4.2.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Comparison
4.3.1 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
4.5 China Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug for Organ Rejection Prophylaxis Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral Liquid
5.2.2 Injection
5.2.3 Capsule
5.3 Market Segment by Type
5.3.1 World Drug for Organ Rejection Prophylaxis Production by Type (2017-2028)
5.3.2 World Drug for Organ Rejection Prophylaxis Production Value by Type (2017-2028)
5.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug for Organ Rejection Prophylaxis Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Drug for Organ Rejection Prophylaxis Production by Application (2017-2028)
6.3.2 World Drug for Organ Rejection Prophylaxis Production Value by Application (2017-2028)
6.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Astellas Pharma US, Inc.
7.1.1 Astellas Pharma US, Inc. Details
7.1.2 Astellas Pharma US, Inc. Major Business
7.1.3 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.1.4 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Astellas Pharma US, Inc. Recent Developments/Updates
7.1.6 Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Details
7.2.2 Pfizer Inc. Major Business
7.2.3 Pfizer Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.2.4 Pfizer Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc. Recent Developments/Updates
7.2.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.3 Bausch Health Companies Inc.
7.3.1 Bausch Health Companies Inc. Details
7.3.2 Bausch Health Companies Inc. Major Business
7.3.3 Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.3.4 Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bausch Health Companies Inc. Recent Developments/Updates
7.3.6 Bausch Health Companies Inc. Competitive Strengths & Weaknesses
7.4 Genentech, Inc.
7.4.1 Genentech, Inc. Details
7.4.2 Genentech, Inc. Major Business
7.4.3 Genentech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.4.4 Genentech, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Genentech, Inc. Recent Developments/Updates
7.4.6 Genentech, Inc. Competitive Strengths & Weaknesses
7.5 Veloxis Pharmaceuticals
7.5.1 Veloxis Pharmaceuticals Details
7.5.2 Veloxis Pharmaceuticals Major Business
7.5.3 Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Product and Services
7.5.4 Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Veloxis Pharmaceuticals Recent Developments/Updates
7.5.6 Veloxis Pharmaceuticals Competitive Strengths & Weaknesses
7.6 AbbVie
7.6.1 AbbVie Details
7.6.2 AbbVie Major Business
7.6.3 AbbVie Drug for Organ Rejection Prophylaxis Product and Services
7.6.4 AbbVie Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AbbVie Recent Developments/Updates
7.6.6 AbbVie Competitive Strengths & Weaknesses
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Details
7.7.2 Bristol Myers Squibb Major Business
7.7.3 Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Product and Services
7.7.4 Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Bristol Myers Squibb Recent Developments/Updates
7.7.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.8 Novartis Pharmaceuticals Corp
7.8.1 Novartis Pharmaceuticals Corp Details
7.8.2 Novartis Pharmaceuticals Corp Major Business
7.8.3 Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Product and Services
7.8.4 Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Novartis Pharmaceuticals Corp Recent Developments/Updates
7.8.6 Novartis Pharmaceuticals Corp Competitive Strengths & Weaknesses
7.9 Sebela Pharmaceuticals Inc.
7.9.1 Sebela Pharmaceuticals Inc. Details
7.9.2 Sebela Pharmaceuticals Inc. Major Business
7.9.3 Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.9.4 Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sebela Pharmaceuticals Inc. Recent Developments/Updates
7.9.6 Sebela Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.10 Janssen Biotech, Inc.
7.10.1 Janssen Biotech, Inc. Details
7.10.2 Janssen Biotech, Inc. Major Business
7.10.3 Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.10.4 Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Janssen Biotech, Inc. Recent Developments/Updates
7.10.6 Janssen Biotech, Inc. Competitive Strengths & Weaknesses
7.11 Astellas Pharma US, Inc.
7.11.1 Astellas Pharma US, Inc. Details
7.11.2 Astellas Pharma US, Inc. Major Business
7.11.3 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.11.4 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Astellas Pharma US, Inc. Recent Developments/Updates
7.11.6 Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
7.12 Adienne Pharma & Biotech
7.12.1 Adienne Pharma & Biotech Details
7.12.2 Adienne Pharma & Biotech Major Business
7.12.3 Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Product and Services
7.12.4 Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Adienne Pharma & Biotech Recent Developments/Updates
7.12.6 Adienne Pharma & Biotech Competitive Strengths & Weaknesses
7.13 Sanofi Genzyme Company
7.13.1 Sanofi Genzyme Company Details
7.13.2 Sanofi Genzyme Company Major Business
7.13.3 Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Product and Services
7.13.4 Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Sanofi Genzyme Company Recent Developments/Updates
7.13.6 Sanofi Genzyme Company Competitive Strengths & Weaknesses
7.14 Heumann Pharma GmbH
7.14.1 Heumann Pharma GmbH Details
7.14.2 Heumann Pharma GmbH Major Business
7.14.3 Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Product and Services
7.14.4 Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Heumann Pharma GmbH Recent Developments/Updates
7.14.6 Heumann Pharma GmbH Competitive Strengths & Weaknesses
7.15 Beijing Shuanglu Pharmaceutical Co., Ltd
7.15.1 Beijing Shuanglu Pharmaceutical Co., Ltd Details
7.15.2 Beijing Shuanglu Pharmaceutical Co., Ltd Major Business
7.15.3 Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.15.4 Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Beijing Shuanglu Pharmaceutical Co., Ltd Recent Developments/Updates
7.15.6 Beijing Shuanglu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.16 North China Pharmaceutical Co., Ltd
7.16.1 North China Pharmaceutical Co., Ltd Details
7.16.2 North China Pharmaceutical Co., Ltd Major Business
7.16.3 North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.16.4 North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 North China Pharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 North China Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
7.17.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Details
7.17.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Major Business
7.17.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.17.4 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Recent Developments/Updates
7.17.6 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.18 Tianjin Central Pharmaceutical Co., Ltd
7.18.1 Tianjin Central Pharmaceutical Co., Ltd Details
7.18.2 Tianjin Central Pharmaceutical Co., Ltd Major Business
7.18.3 Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.18.4 Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Tianjin Central Pharmaceutical Co., Ltd Recent Developments/Updates
7.18.6 Tianjin Central Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.19 Nantong Jingjing Pharmaceutical Co., Ltd
7.19.1 Nantong Jingjing Pharmaceutical Co., Ltd Details
7.19.2 Nantong Jingjing Pharmaceutical Co., Ltd Major Business
7.19.3 Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.19.4 Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Nantong Jingjing Pharmaceutical Co., Ltd Recent Developments/Updates
7.19.6 Nantong Jingjing Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.20 Shanghai Pharmaceutical Group
7.20.1 Shanghai Pharmaceutical Group Details
7.20.2 Shanghai Pharmaceutical Group Major Business
7.20.3 Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Product and Services
7.20.4 Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Shanghai Pharmaceutical Group Recent Developments/Updates
7.20.6 Shanghai Pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drug for Organ Rejection Prophylaxis and Key Manufacturers
8.2 Drug for Organ Rejection Prophylaxis Manufacturing Costs
8.3 Drug for Organ Rejection Prophylaxis Production Process
8.4 Drug for Organ Rejection Prophylaxis Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drug for Organ Rejection Prophylaxis Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drug for Organ Rejection Prophylaxis Typical Distributors
9.3 Drug for Organ Rejection Prophylaxis Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Drug for Organ Rejection Prophylaxis Introduction
1.2 World Drug for Organ Rejection Prophylaxis Supply & Forecast
1.2.1 World Drug for Organ Rejection Prophylaxis Production Value (2017 & 2021 & 2028)
1.2.2 World Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.2.3 World Drug for Organ Rejection Prophylaxis Pricing Trends (2017-2028)
1.3 World Drug for Organ Rejection Prophylaxis Production by Region
1.3.1 World Drug for Organ Rejection Prophylaxis Production Value by Region (2017-2028)
1.3.2 World Drug for Organ Rejection Prophylaxis Production by Region (2017-2028)
1.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Region (2017-2028)
1.3.4 North America Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.5 Europe Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.6 China Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.3.7 Japan Drug for Organ Rejection Prophylaxis Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug for Organ Rejection Prophylaxis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug for Organ Rejection Prophylaxis Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug for Organ Rejection Prophylaxis Demand (2017-2028)
2.2 World Drug for Organ Rejection Prophylaxis Consumption by Region
2.2.1 World Drug for Organ Rejection Prophylaxis Consumption by Region (2017-2022)
2.2.2 World Drug for Organ Rejection Prophylaxis Consumption Forecast by Region (2023-2028)
2.3 United States Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.4 China Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.5 Europe Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.6 Japan Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.7 South Korea Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.8 ASEAN Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
2.9 India Drug for Organ Rejection Prophylaxis Consumption (2017-2028)
3 WORLD DRUG FOR ORGAN REJECTION PROPHYLAXIS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug for Organ Rejection Prophylaxis Production Value by Manufacturer (2017-2022)
3.2 World Drug for Organ Rejection Prophylaxis Production by Manufacturer (2017-2022)
3.3 World Drug for Organ Rejection Prophylaxis Average Price by Manufacturer (2017-2022)
3.4 Drug for Organ Rejection Prophylaxis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug for Organ Rejection Prophylaxis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug for Organ Rejection Prophylaxis in 2021
3.5.3 Global Concentration Ratios (CR8) for Drug for Organ Rejection Prophylaxis in 2021
3.6 Drug for Organ Rejection Prophylaxis Market: Overall Company Footprint Analysis
3.6.1 Drug for Organ Rejection Prophylaxis Market: Region Footprint
3.6.2 Drug for Organ Rejection Prophylaxis Market: Company Product Type Footprint
3.6.3 Drug for Organ Rejection Prophylaxis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Comparison
4.1.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Comparison
4.2.1 United States VS China: Drug for Organ Rejection Prophylaxis Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drug for Organ Rejection Prophylaxis Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Comparison
4.3.1 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drug for Organ Rejection Prophylaxis Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
4.5 China Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drug for Organ Rejection Prophylaxis Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drug for Organ Rejection Prophylaxis in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug for Organ Rejection Prophylaxis Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral Liquid
5.2.2 Injection
5.2.3 Capsule
5.3 Market Segment by Type
5.3.1 World Drug for Organ Rejection Prophylaxis Production by Type (2017-2028)
5.3.2 World Drug for Organ Rejection Prophylaxis Production Value by Type (2017-2028)
5.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug for Organ Rejection Prophylaxis Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialist Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Drug for Organ Rejection Prophylaxis Production by Application (2017-2028)
6.3.2 World Drug for Organ Rejection Prophylaxis Production Value by Application (2017-2028)
6.3.3 World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Astellas Pharma US, Inc.
7.1.1 Astellas Pharma US, Inc. Details
7.1.2 Astellas Pharma US, Inc. Major Business
7.1.3 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.1.4 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Astellas Pharma US, Inc. Recent Developments/Updates
7.1.6 Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Details
7.2.2 Pfizer Inc. Major Business
7.2.3 Pfizer Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.2.4 Pfizer Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc. Recent Developments/Updates
7.2.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.3 Bausch Health Companies Inc.
7.3.1 Bausch Health Companies Inc. Details
7.3.2 Bausch Health Companies Inc. Major Business
7.3.3 Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.3.4 Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bausch Health Companies Inc. Recent Developments/Updates
7.3.6 Bausch Health Companies Inc. Competitive Strengths & Weaknesses
7.4 Genentech, Inc.
7.4.1 Genentech, Inc. Details
7.4.2 Genentech, Inc. Major Business
7.4.3 Genentech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.4.4 Genentech, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Genentech, Inc. Recent Developments/Updates
7.4.6 Genentech, Inc. Competitive Strengths & Weaknesses
7.5 Veloxis Pharmaceuticals
7.5.1 Veloxis Pharmaceuticals Details
7.5.2 Veloxis Pharmaceuticals Major Business
7.5.3 Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Product and Services
7.5.4 Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Veloxis Pharmaceuticals Recent Developments/Updates
7.5.6 Veloxis Pharmaceuticals Competitive Strengths & Weaknesses
7.6 AbbVie
7.6.1 AbbVie Details
7.6.2 AbbVie Major Business
7.6.3 AbbVie Drug for Organ Rejection Prophylaxis Product and Services
7.6.4 AbbVie Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AbbVie Recent Developments/Updates
7.6.6 AbbVie Competitive Strengths & Weaknesses
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Details
7.7.2 Bristol Myers Squibb Major Business
7.7.3 Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Product and Services
7.7.4 Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Bristol Myers Squibb Recent Developments/Updates
7.7.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.8 Novartis Pharmaceuticals Corp
7.8.1 Novartis Pharmaceuticals Corp Details
7.8.2 Novartis Pharmaceuticals Corp Major Business
7.8.3 Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Product and Services
7.8.4 Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Novartis Pharmaceuticals Corp Recent Developments/Updates
7.8.6 Novartis Pharmaceuticals Corp Competitive Strengths & Weaknesses
7.9 Sebela Pharmaceuticals Inc.
7.9.1 Sebela Pharmaceuticals Inc. Details
7.9.2 Sebela Pharmaceuticals Inc. Major Business
7.9.3 Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.9.4 Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Sebela Pharmaceuticals Inc. Recent Developments/Updates
7.9.6 Sebela Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.10 Janssen Biotech, Inc.
7.10.1 Janssen Biotech, Inc. Details
7.10.2 Janssen Biotech, Inc. Major Business
7.10.3 Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.10.4 Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Janssen Biotech, Inc. Recent Developments/Updates
7.10.6 Janssen Biotech, Inc. Competitive Strengths & Weaknesses
7.11 Astellas Pharma US, Inc.
7.11.1 Astellas Pharma US, Inc. Details
7.11.2 Astellas Pharma US, Inc. Major Business
7.11.3 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
7.11.4 Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Astellas Pharma US, Inc. Recent Developments/Updates
7.11.6 Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
7.12 Adienne Pharma & Biotech
7.12.1 Adienne Pharma & Biotech Details
7.12.2 Adienne Pharma & Biotech Major Business
7.12.3 Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Product and Services
7.12.4 Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Adienne Pharma & Biotech Recent Developments/Updates
7.12.6 Adienne Pharma & Biotech Competitive Strengths & Weaknesses
7.13 Sanofi Genzyme Company
7.13.1 Sanofi Genzyme Company Details
7.13.2 Sanofi Genzyme Company Major Business
7.13.3 Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Product and Services
7.13.4 Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Sanofi Genzyme Company Recent Developments/Updates
7.13.6 Sanofi Genzyme Company Competitive Strengths & Weaknesses
7.14 Heumann Pharma GmbH
7.14.1 Heumann Pharma GmbH Details
7.14.2 Heumann Pharma GmbH Major Business
7.14.3 Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Product and Services
7.14.4 Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Heumann Pharma GmbH Recent Developments/Updates
7.14.6 Heumann Pharma GmbH Competitive Strengths & Weaknesses
7.15 Beijing Shuanglu Pharmaceutical Co., Ltd
7.15.1 Beijing Shuanglu Pharmaceutical Co., Ltd Details
7.15.2 Beijing Shuanglu Pharmaceutical Co., Ltd Major Business
7.15.3 Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.15.4 Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Beijing Shuanglu Pharmaceutical Co., Ltd Recent Developments/Updates
7.15.6 Beijing Shuanglu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.16 North China Pharmaceutical Co., Ltd
7.16.1 North China Pharmaceutical Co., Ltd Details
7.16.2 North China Pharmaceutical Co., Ltd Major Business
7.16.3 North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.16.4 North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 North China Pharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 North China Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
7.17.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Details
7.17.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Major Business
7.17.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.17.4 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Recent Developments/Updates
7.17.6 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.18 Tianjin Central Pharmaceutical Co., Ltd
7.18.1 Tianjin Central Pharmaceutical Co., Ltd Details
7.18.2 Tianjin Central Pharmaceutical Co., Ltd Major Business
7.18.3 Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.18.4 Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Tianjin Central Pharmaceutical Co., Ltd Recent Developments/Updates
7.18.6 Tianjin Central Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.19 Nantong Jingjing Pharmaceutical Co., Ltd
7.19.1 Nantong Jingjing Pharmaceutical Co., Ltd Details
7.19.2 Nantong Jingjing Pharmaceutical Co., Ltd Major Business
7.19.3 Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
7.19.4 Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Nantong Jingjing Pharmaceutical Co., Ltd Recent Developments/Updates
7.19.6 Nantong Jingjing Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.20 Shanghai Pharmaceutical Group
7.20.1 Shanghai Pharmaceutical Group Details
7.20.2 Shanghai Pharmaceutical Group Major Business
7.20.3 Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Product and Services
7.20.4 Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Shanghai Pharmaceutical Group Recent Developments/Updates
7.20.6 Shanghai Pharmaceutical Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drug for Organ Rejection Prophylaxis and Key Manufacturers
8.2 Drug for Organ Rejection Prophylaxis Manufacturing Costs
8.3 Drug for Organ Rejection Prophylaxis Production Process
8.4 Drug for Organ Rejection Prophylaxis Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drug for Organ Rejection Prophylaxis Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drug for Organ Rejection Prophylaxis Typical Distributors
9.3 Drug for Organ Rejection Prophylaxis Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Drug for Organ Rejection Prophylaxis Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drug for Organ Rejection Prophylaxis Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drug for Organ Rejection Prophylaxis Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2017-2022)
Table 5. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2023-2028)
Table 6. World Drug for Organ Rejection Prophylaxis Production by Region (2017-2022) & (K Units)
Table 7. World Drug for Organ Rejection Prophylaxis Production by Region (2023-2028) & (K Units)
Table 8. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2017-2022)
Table 9. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2023-2028)
Table 10. World Drug for Organ Rejection Prophylaxis Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drug for Organ Rejection Prophylaxis Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drug for Organ Rejection Prophylaxis Major Market Trends
Table 13. World Drug for Organ Rejection Prophylaxis Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drug for Organ Rejection Prophylaxis Consumption by Region (2017-2022) & (K Units)
Table 15. World Drug for Organ Rejection Prophylaxis Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drug for Organ Rejection Prophylaxis Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drug for Organ Rejection Prophylaxis Producers in 2021
Table 18. World Drug for Organ Rejection Prophylaxis Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drug for Organ Rejection Prophylaxis Producers in 2021
Table 20. World Drug for Organ Rejection Prophylaxis Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drug for Organ Rejection Prophylaxis Company Evaluation Quadrant
Table 22. World Drug for Organ Rejection Prophylaxis Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drug for Organ Rejection Prophylaxis Production Site of Key Manufacturer
Table 24. Drug for Organ Rejection Prophylaxis Market: Company Product Type Footprint
Table 25. Drug for Organ Rejection Prophylaxis Market: Company Product Application Footprint
Table 26. Drug for Organ Rejection Prophylaxis Competitive Factors
Table 27. Drug for Organ Rejection Prophylaxis New Entrant and Capacity Expansion Plans
Table 28. Drug for Organ Rejection Prophylaxis Mergers & Acquisitions Activity
Table 29. United States VS China Drug for Organ Rejection Prophylaxis Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drug for Organ Rejection Prophylaxis Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drug for Organ Rejection Prophylaxis Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drug for Organ Rejection Prophylaxis in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drug for Organ Rejection Prophylaxis in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drug for Organ Rejection Prophylaxis in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drug for Organ Rejection Prophylaxis Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drug for Organ Rejection Prophylaxis Production by Type (2017-2022) & (K Units)
Table 49. World Drug for Organ Rejection Prophylaxis Production by Type (2023-2028) & (K Units)
Table 50. World Drug for Organ Rejection Prophylaxis Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drug for Organ Rejection Prophylaxis Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drug for Organ Rejection Prophylaxis Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drug for Organ Rejection Prophylaxis Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drug for Organ Rejection Prophylaxis Production by Application (2017-2022) & (K Units)
Table 56. World Drug for Organ Rejection Prophylaxis Production by Application (2023-2028) & (K Units)
Table 57. World Drug for Organ Rejection Prophylaxis Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drug for Organ Rejection Prophylaxis Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drug for Organ Rejection Prophylaxis Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Astellas Pharma US, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Astellas Pharma US, Inc. Major Business
Table 63. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 64. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Astellas Pharma US, Inc. Recent Developments/Updates
Table 66. Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
Table 67. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc. Major Business
Table 69. Pfizer Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 70. Pfizer Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc. Recent Developments/Updates
Table 72. Pfizer Inc. Competitive Strengths & Weaknesses
Table 73. Bausch Health Companies Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Bausch Health Companies Inc. Major Business
Table 75. Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 76. Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bausch Health Companies Inc. Recent Developments/Updates
Table 78. Bausch Health Companies Inc. Competitive Strengths & Weaknesses
Table 79. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Genentech, Inc. Major Business
Table 81. Genentech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 82. Genentech, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Genentech, Inc. Recent Developments/Updates
Table 84. Genentech, Inc. Competitive Strengths & Weaknesses
Table 85. Veloxis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Veloxis Pharmaceuticals Major Business
Table 87. Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Product and Services
Table 88. Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Veloxis Pharmaceuticals Recent Developments/Updates
Table 90. Veloxis Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. AbbVie Basic Information, Manufacturing Base and Competitors
Table 92. AbbVie Major Business
Table 93. AbbVie Drug for Organ Rejection Prophylaxis Product and Services
Table 94. AbbVie Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AbbVie Recent Developments/Updates
Table 96. AbbVie Competitive Strengths & Weaknesses
Table 97. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 98. Bristol Myers Squibb Major Business
Table 99. Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Product and Services
Table 100. Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Bristol Myers Squibb Recent Developments/Updates
Table 102. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 103. Novartis Pharmaceuticals Corp Basic Information, Manufacturing Base and Competitors
Table 104. Novartis Pharmaceuticals Corp Major Business
Table 105. Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Product and Services
Table 106. Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Novartis Pharmaceuticals Corp Recent Developments/Updates
Table 108. Novartis Pharmaceuticals Corp Competitive Strengths & Weaknesses
Table 109. Sebela Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Sebela Pharmaceuticals Inc. Major Business
Table 111. Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 112. Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Sebela Pharmaceuticals Inc. Recent Developments/Updates
Table 114. Sebela Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 115. Janssen Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Janssen Biotech, Inc. Major Business
Table 117. Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 118. Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Janssen Biotech, Inc. Recent Developments/Updates
Table 120. Janssen Biotech, Inc. Competitive Strengths & Weaknesses
Table 121. Astellas Pharma US, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Astellas Pharma US, Inc. Major Business
Table 123. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 124. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Astellas Pharma US, Inc. Recent Developments/Updates
Table 126. Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
Table 127. Adienne Pharma & Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Adienne Pharma & Biotech Major Business
Table 129. Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Product and Services
Table 130. Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Adienne Pharma & Biotech Recent Developments/Updates
Table 132. Adienne Pharma & Biotech Competitive Strengths & Weaknesses
Table 133. Sanofi Genzyme Company Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi Genzyme Company Major Business
Table 135. Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Product and Services
Table 136. Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Sanofi Genzyme Company Recent Developments/Updates
Table 138. Sanofi Genzyme Company Competitive Strengths & Weaknesses
Table 139. Heumann Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 140. Heumann Pharma GmbH Major Business
Table 141. Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Product and Services
Table 142. Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Heumann Pharma GmbH Recent Developments/Updates
Table 144. Heumann Pharma GmbH Competitive Strengths & Weaknesses
Table 145. Beijing Shuanglu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Beijing Shuanglu Pharmaceutical Co., Ltd Major Business
Table 147. Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 148. Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Beijing Shuanglu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Beijing Shuanglu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 151. North China Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. North China Pharmaceutical Co., Ltd Major Business
Table 153. North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 154. North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. North China Pharmaceutical Co., Ltd Recent Developments/Updates
Table 156. North China Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 157. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Major Business
Table 159. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 160. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Recent Developments/Updates
Table 162. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 163. Tianjin Central Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Tianjin Central Pharmaceutical Co., Ltd Major Business
Table 165. Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 166. Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Tianjin Central Pharmaceutical Co., Ltd Recent Developments/Updates
Table 168. Tianjin Central Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 169. Nantong Jingjing Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Nantong Jingjing Pharmaceutical Co., Ltd Major Business
Table 171. Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 172. Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Nantong Jingjing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 174. Shanghai Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 175. Shanghai Pharmaceutical Group Major Business
Table 176. Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Product and Services
Table 177. Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Drug for Organ Rejection Prophylaxis Raw Material
Table 179. Key Manufacturers of Drug for Organ Rejection Prophylaxis Raw Materials
Table 180. Drug for Organ Rejection Prophylaxis Typical Distributors
Table 181. Drug for Organ Rejection Prophylaxis Typical Customers
Table 1. World Drug for Organ Rejection Prophylaxis Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drug for Organ Rejection Prophylaxis Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drug for Organ Rejection Prophylaxis Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2017-2022)
Table 5. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2023-2028)
Table 6. World Drug for Organ Rejection Prophylaxis Production by Region (2017-2022) & (K Units)
Table 7. World Drug for Organ Rejection Prophylaxis Production by Region (2023-2028) & (K Units)
Table 8. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2017-2022)
Table 9. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2023-2028)
Table 10. World Drug for Organ Rejection Prophylaxis Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drug for Organ Rejection Prophylaxis Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drug for Organ Rejection Prophylaxis Major Market Trends
Table 13. World Drug for Organ Rejection Prophylaxis Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drug for Organ Rejection Prophylaxis Consumption by Region (2017-2022) & (K Units)
Table 15. World Drug for Organ Rejection Prophylaxis Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drug for Organ Rejection Prophylaxis Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drug for Organ Rejection Prophylaxis Producers in 2021
Table 18. World Drug for Organ Rejection Prophylaxis Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drug for Organ Rejection Prophylaxis Producers in 2021
Table 20. World Drug for Organ Rejection Prophylaxis Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drug for Organ Rejection Prophylaxis Company Evaluation Quadrant
Table 22. World Drug for Organ Rejection Prophylaxis Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drug for Organ Rejection Prophylaxis Production Site of Key Manufacturer
Table 24. Drug for Organ Rejection Prophylaxis Market: Company Product Type Footprint
Table 25. Drug for Organ Rejection Prophylaxis Market: Company Product Application Footprint
Table 26. Drug for Organ Rejection Prophylaxis Competitive Factors
Table 27. Drug for Organ Rejection Prophylaxis New Entrant and Capacity Expansion Plans
Table 28. Drug for Organ Rejection Prophylaxis Mergers & Acquisitions Activity
Table 29. United States VS China Drug for Organ Rejection Prophylaxis Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drug for Organ Rejection Prophylaxis Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drug for Organ Rejection Prophylaxis Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drug for Organ Rejection Prophylaxis in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drug for Organ Rejection Prophylaxis in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drug for Organ Rejection Prophylaxis in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drug for Organ Rejection Prophylaxis Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drug for Organ Rejection Prophylaxis Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drug for Organ Rejection Prophylaxis Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drug for Organ Rejection Prophylaxis Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drug for Organ Rejection Prophylaxis Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drug for Organ Rejection Prophylaxis Production by Type (2017-2022) & (K Units)
Table 49. World Drug for Organ Rejection Prophylaxis Production by Type (2023-2028) & (K Units)
Table 50. World Drug for Organ Rejection Prophylaxis Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drug for Organ Rejection Prophylaxis Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drug for Organ Rejection Prophylaxis Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drug for Organ Rejection Prophylaxis Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drug for Organ Rejection Prophylaxis Production by Application (2017-2022) & (K Units)
Table 56. World Drug for Organ Rejection Prophylaxis Production by Application (2023-2028) & (K Units)
Table 57. World Drug for Organ Rejection Prophylaxis Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drug for Organ Rejection Prophylaxis Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drug for Organ Rejection Prophylaxis Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Astellas Pharma US, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Astellas Pharma US, Inc. Major Business
Table 63. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 64. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Astellas Pharma US, Inc. Recent Developments/Updates
Table 66. Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
Table 67. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc. Major Business
Table 69. Pfizer Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 70. Pfizer Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc. Recent Developments/Updates
Table 72. Pfizer Inc. Competitive Strengths & Weaknesses
Table 73. Bausch Health Companies Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Bausch Health Companies Inc. Major Business
Table 75. Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 76. Bausch Health Companies Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bausch Health Companies Inc. Recent Developments/Updates
Table 78. Bausch Health Companies Inc. Competitive Strengths & Weaknesses
Table 79. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Genentech, Inc. Major Business
Table 81. Genentech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 82. Genentech, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Genentech, Inc. Recent Developments/Updates
Table 84. Genentech, Inc. Competitive Strengths & Weaknesses
Table 85. Veloxis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Veloxis Pharmaceuticals Major Business
Table 87. Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Product and Services
Table 88. Veloxis Pharmaceuticals Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Veloxis Pharmaceuticals Recent Developments/Updates
Table 90. Veloxis Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. AbbVie Basic Information, Manufacturing Base and Competitors
Table 92. AbbVie Major Business
Table 93. AbbVie Drug for Organ Rejection Prophylaxis Product and Services
Table 94. AbbVie Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AbbVie Recent Developments/Updates
Table 96. AbbVie Competitive Strengths & Weaknesses
Table 97. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 98. Bristol Myers Squibb Major Business
Table 99. Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Product and Services
Table 100. Bristol Myers Squibb Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Bristol Myers Squibb Recent Developments/Updates
Table 102. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 103. Novartis Pharmaceuticals Corp Basic Information, Manufacturing Base and Competitors
Table 104. Novartis Pharmaceuticals Corp Major Business
Table 105. Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Product and Services
Table 106. Novartis Pharmaceuticals Corp Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Novartis Pharmaceuticals Corp Recent Developments/Updates
Table 108. Novartis Pharmaceuticals Corp Competitive Strengths & Weaknesses
Table 109. Sebela Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Sebela Pharmaceuticals Inc. Major Business
Table 111. Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 112. Sebela Pharmaceuticals Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Sebela Pharmaceuticals Inc. Recent Developments/Updates
Table 114. Sebela Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 115. Janssen Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Janssen Biotech, Inc. Major Business
Table 117. Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 118. Janssen Biotech, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Janssen Biotech, Inc. Recent Developments/Updates
Table 120. Janssen Biotech, Inc. Competitive Strengths & Weaknesses
Table 121. Astellas Pharma US, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Astellas Pharma US, Inc. Major Business
Table 123. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Product and Services
Table 124. Astellas Pharma US, Inc. Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Astellas Pharma US, Inc. Recent Developments/Updates
Table 126. Astellas Pharma US, Inc. Competitive Strengths & Weaknesses
Table 127. Adienne Pharma & Biotech Basic Information, Manufacturing Base and Competitors
Table 128. Adienne Pharma & Biotech Major Business
Table 129. Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Product and Services
Table 130. Adienne Pharma & Biotech Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Adienne Pharma & Biotech Recent Developments/Updates
Table 132. Adienne Pharma & Biotech Competitive Strengths & Weaknesses
Table 133. Sanofi Genzyme Company Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi Genzyme Company Major Business
Table 135. Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Product and Services
Table 136. Sanofi Genzyme Company Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Sanofi Genzyme Company Recent Developments/Updates
Table 138. Sanofi Genzyme Company Competitive Strengths & Weaknesses
Table 139. Heumann Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 140. Heumann Pharma GmbH Major Business
Table 141. Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Product and Services
Table 142. Heumann Pharma GmbH Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Heumann Pharma GmbH Recent Developments/Updates
Table 144. Heumann Pharma GmbH Competitive Strengths & Weaknesses
Table 145. Beijing Shuanglu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Beijing Shuanglu Pharmaceutical Co., Ltd Major Business
Table 147. Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 148. Beijing Shuanglu Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Beijing Shuanglu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Beijing Shuanglu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 151. North China Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. North China Pharmaceutical Co., Ltd Major Business
Table 153. North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 154. North China Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. North China Pharmaceutical Co., Ltd Recent Developments/Updates
Table 156. North China Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 157. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Major Business
Table 159. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 160. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Recent Developments/Updates
Table 162. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 163. Tianjin Central Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Tianjin Central Pharmaceutical Co., Ltd Major Business
Table 165. Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 166. Tianjin Central Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Tianjin Central Pharmaceutical Co., Ltd Recent Developments/Updates
Table 168. Tianjin Central Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 169. Nantong Jingjing Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Nantong Jingjing Pharmaceutical Co., Ltd Major Business
Table 171. Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Product and Services
Table 172. Nantong Jingjing Pharmaceutical Co., Ltd Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Nantong Jingjing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 174. Shanghai Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 175. Shanghai Pharmaceutical Group Major Business
Table 176. Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Product and Services
Table 177. Shanghai Pharmaceutical Group Drug for Organ Rejection Prophylaxis Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Drug for Organ Rejection Prophylaxis Raw Material
Table 179. Key Manufacturers of Drug for Organ Rejection Prophylaxis Raw Materials
Table 180. Drug for Organ Rejection Prophylaxis Typical Distributors
Table 181. Drug for Organ Rejection Prophylaxis Typical Customers
LIST OF FIGURES
Figure 1. Drug for Organ Rejection Prophylaxis Picture
Figure 2. World Drug for Organ Rejection Prophylaxis Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drug for Organ Rejection Prophylaxis Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 5. World Drug for Organ Rejection Prophylaxis Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2017-2028)
Figure 7. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2017-2028)
Figure 8. North America Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 9. Europe Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 10. China Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 11. Japan Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 12. Drug for Organ Rejection Prophylaxis Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug for Organ Rejection Prophylaxis Demand (2017-2028) & (K Units)
Figure 15. World Drug for Organ Rejection Prophylaxis Consumption Market Share by Region (2017-2028)
Figure 16. United States Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 17. China Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 18. Europe Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 19. Japan Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 22. India Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drug for Organ Rejection Prophylaxis by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug for Organ Rejection Prophylaxis Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug for Organ Rejection Prophylaxis Markets in 2021
Figure 26. United States VS China: Drug for Organ Rejection Prophylaxis Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drug for Organ Rejection Prophylaxis Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drug for Organ Rejection Prophylaxis Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in United States
Figure 30. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in China
Figure 31. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in Rest of World
Figure 32. World Drug for Organ Rejection Prophylaxis Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Type in 2021
Figure 34. Oral Liquid
Figure 35. Injection
Figure 36. Capsule
Figure 37. World Drug for Organ Rejection Prophylaxis Production Market Share by Type (2017-2028)
Figure 38. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Type (2017-2028)
Figure 39. World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drug for Organ Rejection Prophylaxis Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Specialist Clinic
Figure 44. Other
Figure 45. World Drug for Organ Rejection Prophylaxis Production Market Share by Application (2017-2028)
Figure 46. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Application (2017-2028)
Figure 47. World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Drug for Organ Rejection Prophylaxis in 2021
Figure 49. Manufacturing Process Analysis of Drug for Organ Rejection Prophylaxis
Figure 50. Drug for Organ Rejection Prophylaxis Industrial Chain
Figure 51. Distribution Channel Breakdown for Drug for Organ Rejection Prophylaxis Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Drug for Organ Rejection Prophylaxis Picture
Figure 2. World Drug for Organ Rejection Prophylaxis Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drug for Organ Rejection Prophylaxis Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 5. World Drug for Organ Rejection Prophylaxis Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Region (2017-2028)
Figure 7. World Drug for Organ Rejection Prophylaxis Production Market Share by Region (2017-2028)
Figure 8. North America Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 9. Europe Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 10. China Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 11. Japan Drug for Organ Rejection Prophylaxis Production (2017-2028) & (K Units)
Figure 12. Drug for Organ Rejection Prophylaxis Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug for Organ Rejection Prophylaxis Demand (2017-2028) & (K Units)
Figure 15. World Drug for Organ Rejection Prophylaxis Consumption Market Share by Region (2017-2028)
Figure 16. United States Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 17. China Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 18. Europe Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 19. Japan Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 22. India Drug for Organ Rejection Prophylaxis Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drug for Organ Rejection Prophylaxis by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug for Organ Rejection Prophylaxis Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug for Organ Rejection Prophylaxis Markets in 2021
Figure 26. United States VS China: Drug for Organ Rejection Prophylaxis Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drug for Organ Rejection Prophylaxis Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drug for Organ Rejection Prophylaxis Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in United States
Figure 30. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in China
Figure 31. Key Producers and Market Share of Drug for Organ Rejection Prophylaxis in Rest of World
Figure 32. World Drug for Organ Rejection Prophylaxis Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Type in 2021
Figure 34. Oral Liquid
Figure 35. Injection
Figure 36. Capsule
Figure 37. World Drug for Organ Rejection Prophylaxis Production Market Share by Type (2017-2028)
Figure 38. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Type (2017-2028)
Figure 39. World Drug for Organ Rejection Prophylaxis Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drug for Organ Rejection Prophylaxis Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Specialist Clinic
Figure 44. Other
Figure 45. World Drug for Organ Rejection Prophylaxis Production Market Share by Application (2017-2028)
Figure 46. World Drug for Organ Rejection Prophylaxis Production Value Market Share by Application (2017-2028)
Figure 47. World Drug for Organ Rejection Prophylaxis Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Drug for Organ Rejection Prophylaxis in 2021
Figure 49. Manufacturing Process Analysis of Drug for Organ Rejection Prophylaxis
Figure 50. Drug for Organ Rejection Prophylaxis Industrial Chain
Figure 51. Distribution Channel Breakdown for Drug for Organ Rejection Prophylaxis Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
